Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03744390 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion pushed from Mar 18, 2026 to Dec 18, 2026v13
  2. Site details revised at 1 of 22 sitesv12
  3. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Feb 18, 2023 to Mar 18, 2026
    • Site details revised at 22 of 22 sites
    v11
  4. Site details revised at 1 of 22 sitesv10
  5. Study sites: 20 to 22v9
Show 7 earlier versionsHide 7 earlier versions
  1. Study sites: 18 to 20v8
  2. Primary completion date: Feb 18, 2021 to Feb 18, 2023
    • Study sites: 17 to 18
    v7
  3. Start date: Feb 12, 2019 to Apr 2, 2019
    • Primary completion date: Jan 12, 2021 to Feb 18, 2021
    • Study completion date: Jan 12, 2023 to Feb 18, 2023
    v6
  4. Study sites: 9 to 17v5
  5. Study sites: 1 to 9v4
  6. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 12, 2019 to Feb 12, 2019
    v3
  7. Start date: Nov 12, 2018 to Jan 12, 2019
    • Primary completion date: Nov 12, 2021 to Jan 12, 2021
    • Study completion date: Nov 12, 2023 to Jan 12, 2023
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
patients with MDS (Myelodysplastic Syndrome) and mutated IDH2 patients will be treated with AG221 (IDH2 inhibitor)
Trial Details
NCT Number NCT03744390
Lead Sponsor Groupe Francophone des Myelodysplasies
Conditions
(from sponsor)		 Myelodysplastic Syndromes, Leukemia Acute Myeloid
Related terms Leukemia, Myeloid, Acute, Myelodysplastic Syndromes
Enrollment 68 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov